Arkolith/Insider Trading/DSGN/Form 4

SR One Capital Management, LLC

10% OwnerDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Apr 1, 2021
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)937K——5.4M
Mar 30, 2021Conversion(C)4.4M——4.4M
Mar 30, 2021Buy(P)250K$20.00$5.0M5.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)1.5M—$00
Mar 30, 2021Conversion(C)7.2M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-024238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML